NWPF

News ArchivesRead News

New Insights Could Help in Battle to Beat Parkinson's Disease

Thursday June 26, 2014

Medical Xpress - Scientists have taken a step closer to understanding the causes of Parkinson's disease, identifying what's happening at a cellular level to potentially help develop future treatments.

Researchers at the University of Bristol, and their US-based collaborators at the University of Texas Southwestern Medical Center and the Mayo Clinic, have shown that a genetic change, known as a mutation, impairs the ability to transport proteins correctly within cells.

Being starved of these proteins could be part of why the body loses nerve cells in the part of the brain responsible for producing the chemical dopamine which helps control and co-ordinate body movements.

A mutation in the VPS35 gene is known to be linked to Parkinson's disease, but experts have not been able to pinpoint its role until now.

The results, published online in Current Biology today [June 26], reveal that the VPS35 mutation impairs the cell's ability to transport a sub-set of cargo proteins to their correct destinations.

They also identified three additional proteins affected by this mutation, some of which are already linked with Parkinson's disease, which affects one in 500 people in the UK.

Professor Peter Cullen, from the School of Biochemistry at the University of Bristol, said: "The discovery of the molecular defect associated with the VPS35 mutation offers a potentially exciting avenue of research into the causes of this disease. This research significantly adds to the growing body of evidence that the retromer complex, which VPS35 is a part of, is a potential therapeutic target when designing drugs to help combat this and other neurodegenerative diseases."

(26 June 2014). Mexical Xpress. New insights could help in battle to beat Parkinson's disease. http://medicalxpress.com/news/2014-06-insights-parkinson-disease.html

Recent News

Oct 18 - Fighting Parkinson's disease through dance
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show